Evidence map›Paper›PMID 40298638›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Characterization of Systemic Oxidative Stress in Asthmatic Adults Compared to Healthy Controls and Its Association with the Oxidative Potential of Particulate Matter Collected Using Personal Samplers.

Miguel Santibáñez, Adriana Núñez-Robainas, Esther Barreiro, Andrea Expósito, Juan Agüero, Juan Luis García-Rivero, Beatriz Abascal, Carlos Antonio Amado, Juan José Ruiz-Cubillán, Carmen Fernández-Sobaler and 3 more

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Miguel SantibáñezGlobal Health Research Group, Departamento Enfermería, Faculty of Nursing, Universidad de Cantabria-IDIVAL, Avda. Valdecilla, s/n, 39008 Santander, Spain.ORCID 0000-0003-2634-615X
Adriana Núñez-RobainasCentro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 08003 Barcelona, Spain.ORCID 0000-0002-5891-5022
Esther BarreiroCentro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 08003 Barcelona, Spain.
Andrea ExpósitoDepartamento de Ingenierías Química y Biomolecular, Universidad de Cantabria, Avda. Los Castros, s/n, 39005 Santander, Spain.ORCID 0000-0002-5465-5913
Juan AgüeroDivision of Pneumology, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39008 Santander, Spain.
Juan Luis García-RiveroDivision of Pneumology, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39008 Santander, Spain.ORCID 0000-0002-6407-5832
Beatriz AbascalDivision of Pneumology, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39008 Santander, Spain.
Carlos Antonio AmadoDivision of Pneumology, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39008 Santander, Spain.ORCID 0000-0002-5598-1753
Juan José Ruiz-CubillánDivision of Pneumology, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39008 Santander, Spain.ORCID 0000-0002-7251-0232
Carmen Fernández-SobalerDivision of Biochemistry, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39008 Santander, Spain.
María Teresa García-UnzuetaDivision of Biochemistry, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39008 Santander, Spain.ORCID 0000-0003-2531-3284
José Manuel CifriánDivision of Pneumology, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39008 Santander, Spain.ORCID 0000-0003-3682-0142
Ignacio Fernandez-OlmoDepartamento de Ingenierías Química y Biomolecular, Universidad de Cantabria, Avda. Los Castros, s/n, 39005 Santander, Spain.

Funding

Ministerio de Ciencia, Innovación y Universidades (Project PID2020-114787RBI00, funded by MCIN/AEI/10.13039/501100011033 and "ERDF A way of making Europe").Spanish Society of Pneumology (SEPAR Nº 1383/23; Nº 1616/24)
6 · The paper itself

Abstract

Inflammatory cell activation in asthma may lead to reactive oxygen species (ROS) overproduction with an imbalance between oxidant levels and antioxidant capacity, called oxidative stress (OS). Since particulate matter (PM) airborne exposure may also contribute to ROS generation, it is unclear whether PM contributes more to OS than inflammatory cell activation. In our ASTHMA-FENOP study, which included 44 asthma patients and 37 matched controls, we aimed to characterize OS using five serum markers: total ROS content, protein carbonyl content, oxidized low-density lipoprotein (OxLDL), 8-hydroxydeoxyguanosine, and glutathione. Volunteers wore personal samplers for 24 h, collecting fine and coarse PM fractions separately, and the oxidative potential (OP) was determined using two methods. We observed differences between asthmatic and non-asthmatic volunteers in some OS markers, such as OxLDL, with an adjusted mean difference of 50,059.8 ng/mL (

Indexed as

asthmaoxidative potential (OP)OxLDLparticulate matter (PM)systemic oxidative stress

Identifiers

PMID40298638
PMCPMC12024361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.